Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01174095 · ClinicalTrials.gov registry record
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 31
- Enrollment target
NCT01174095 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 31 participants.
The verdict
NCT01174095 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The primary aim of the study is to assess and follow-up subjects that received AdGVVEGF121cDNA in IRB protocol #0794-894 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individuals with Diffuse Coronary Artery Disease" and IRB protocol #0297-693 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individuals with Diffuse Coronary Artery Disease Via Minimally Invasive Surgery".
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01174095
The ClinicalTrials.gov registry entry for NCT01174095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01174095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01174095 about?
NCT01174095 is a clinical study titled "Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy". The primary aim of the study is to assess and follow-up subjects that received AdGVVEGF121cDNA in IRB protocol #0794-894 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individual...
What is the current status of trial NCT01174095?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2009-05. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01174095?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.